Village Counseling & Wellness Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 W Main St Ste 6, Ovilla, TX 75154 Phone: 469-808-9730 Fax: 469-275-9246 |
Long-washington Counseling And Consulting Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 700 W Main St Ste 3, Ovilla, TX 75154 Phone: 214-945-0232 |
Total Therapies And Wellness Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 700 W Main St Ste 4, Ovilla, TX 75154 Phone: 214-945-0232 |
Bridgeway Life Development Foundation Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 700 W Main St Ste 4, Ovilla, TX 75154 Phone: 214-945-0232 |
News Archive
Newsweek in its Oct. 6 issue examines malaria eradication efforts and the Global Malaria Action Plan, which aims to eradicate malaria worldwide and was released last week during the United Nations General Assembly High-Level Meeting on the U.N. Millennium Development Goals (Carmichael/Cunningham, Newsweek, 10/6).
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.
Broadlane, the leading end-to-end cost-management partner for healthcare providers, announced today that New Hanover Regional Medical Center, in Wilmington, North Carolina, has renewed its supply chain relationship with Broadlane for another five years. New Hanover will continue to access Broadlane's unparalleled national contract portfolio of consumable supplies, equipment, pharmaceuticals and purchased services to help manage approximately $130 million in annual supply spend.
It was clear at a relatively early stage of the pandemic that SARS-CoV-2 causes a wide range of symptoms; in addition to typical respiratory symptoms, patients also had neurological symptoms (starting with anosmia), gastrointestinal symptoms, elevated liver values, and renal, urinary or hematological changes, for example.
Sinapis Pharma, Inc. has successfully completed a Bridge financing to continue to support its drug development program. Sinapis Pharma has discovered and is developing a novel therapeutic approach to neuronal protection using its intravenous methamphetamine technology. The company has strong pre-clinical data in stroke and traumatic brain injury animal models conclusively demonstrating a 12-hour therapeutic window and multiple pathway neuroprotection.
› Verified 6 days ago